ZA89552B - Pharmaceutical composition for 4-aroylimidazol-2-ones - Google Patents
Pharmaceutical composition for 4-aroylimidazol-2-onesInfo
- Publication number
- ZA89552B ZA89552B ZA89552A ZA89552A ZA89552B ZA 89552 B ZA89552 B ZA 89552B ZA 89552 A ZA89552 A ZA 89552A ZA 89552 A ZA89552 A ZA 89552A ZA 89552 B ZA89552 B ZA 89552B
- Authority
- ZA
- South Africa
- Prior art keywords
- aroylimidazol
- ones
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
- 
        - A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
 
- 
        - A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
 
- 
        - A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
 
- 
        - A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
 
- 
        - A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
 
- 
        - A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
 
- 
        - A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
 
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| US14980388A | 1988-01-29 | 1988-01-29 | 
Publications (1)
| Publication Number | Publication Date | 
|---|---|
| ZA89552B true ZA89552B (en) | 1989-10-25 | 
Family
ID=22531858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date | 
|---|---|---|---|
| ZA89552A ZA89552B (en) | 1988-01-29 | 1989-01-24 | Pharmaceutical composition for 4-aroylimidazol-2-ones | 
Country Status (17)
| Country | Link | 
|---|---|
| EP (1) | EP0326103B1 (en:Method) | 
| JP (1) | JPH01226817A (en:Method) | 
| KR (1) | KR890011594A (en:Method) | 
| CN (1) | CN1035242A (en:Method) | 
| AR (1) | AR241632A1 (en:Method) | 
| AT (1) | ATE78161T1 (en:Method) | 
| AU (1) | AU611757B2 (en:Method) | 
| DE (1) | DE68902056T2 (en:Method) | 
| DK (1) | DK169566B1 (en:Method) | 
| ES (1) | ES2051898T3 (en:Method) | 
| GR (1) | GR3005792T3 (en:Method) | 
| HU (1) | HUT49282A (en:Method) | 
| IE (1) | IE62426B1 (en:Method) | 
| IL (1) | IL89049A0 (en:Method) | 
| NZ (1) | NZ227700A (en:Method) | 
| PT (1) | PT89561B (en:Method) | 
| ZA (1) | ZA89552B (en:Method) | 
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| DK0448091T3 (da) * | 1990-03-23 | 1999-05-03 | Yoshitomi Pharmaceutical | Farmaceutisk præparat indeholdende et i ringe grad vandopløseligt medikament | 
| AU2004299058A1 (en) * | 2003-12-12 | 2005-06-30 | Aventis Pharmaceutical, Inc. | Enoximone formulations and their use in the treatment of cardiac hypertrophy and heart failure | 
| CA2572179A1 (en) * | 2004-06-23 | 2006-01-19 | Myogen, Inc. | Enoximone formulations and their use in the treatment of pde-iii mediated diseases | 
| EP2581082B1 (de) | 2011-10-10 | 2015-12-30 | Carinopharm GmbH | Pharmazeutische Zusammensetzung zur Behandlung von Status asthmaticus | 
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| US4405635A (en) * | 1979-06-18 | 1983-09-20 | Merrell Dow Pharmaceuticals Inc. | 4-Aroylimidazol-2-ones and their use as pharmaceuticals | 
| EP0031603A1 (en) * | 1979-12-31 | 1981-07-08 | American Cyanamid Company | Pharmaceutical composition of matter | 
| OA06863A (fr) * | 1980-08-04 | 1983-02-28 | Merck & Co Inc | Solubilisation de l'invermectine dans l'eau. | 
| DE3307422A1 (de) * | 1983-03-03 | 1984-09-06 | Bayer Ag, 5090 Leverkusen | Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen | 
| EP0179583A1 (en) * | 1984-10-04 | 1986-04-30 | Merck & Co. Inc. | A system for enhancing the water dissolution rate and solubility of poorly soluble drugs | 
- 
        1989
        - 1989-01-24 NZ NZ227700A patent/NZ227700A/xx unknown
- 1989-01-24 ZA ZA89552A patent/ZA89552B/xx unknown
- 1989-01-24 IL IL89049A patent/IL89049A0/xx unknown
- 1989-01-25 AT AT89101268T patent/ATE78161T1/de not_active IP Right Cessation
- 1989-01-25 AU AU28768/89A patent/AU611757B2/en not_active Expired
- 1989-01-25 ES ES89101268T patent/ES2051898T3/es not_active Expired - Lifetime
- 1989-01-25 DE DE8989101268T patent/DE68902056T2/de not_active Expired - Lifetime
- 1989-01-25 AR AR89313066A patent/AR241632A1/es active
- 1989-01-25 EP EP89101268A patent/EP0326103B1/en not_active Expired - Lifetime
- 1989-01-27 HU HU89428A patent/HUT49282A/hu unknown
- 1989-01-27 DK DK037589A patent/DK169566B1/da not_active IP Right Cessation
- 1989-01-27 JP JP1016542A patent/JPH01226817A/ja active Pending
- 1989-01-27 PT PT89561A patent/PT89561B/pt not_active IP Right Cessation
- 1989-01-27 IE IE27589A patent/IE62426B1/en not_active IP Right Cessation
- 1989-01-28 KR KR1019890000960A patent/KR890011594A/ko not_active Ceased
- 1989-01-28 CN CN89100532A patent/CN1035242A/zh active Pending
 
- 
        1992
        - 1992-09-24 GR GR920402114T patent/GR3005792T3/el unknown
 
Also Published As
| Publication number | Publication date | 
|---|---|
| HUT49282A (en) | 1989-09-28 | 
| AU2876889A (en) | 1989-08-03 | 
| IL89049A0 (en) | 1989-08-15 | 
| KR890011594A (ko) | 1989-08-21 | 
| CN1035242A (zh) | 1989-09-06 | 
| PT89561B (pt) | 1994-01-31 | 
| DK169566B1 (da) | 1994-12-05 | 
| AU611757B2 (en) | 1991-06-20 | 
| NZ227700A (en) | 1990-09-26 | 
| ES2051898T3 (es) | 1994-07-01 | 
| IE890275L (en) | 1989-07-29 | 
| EP0326103A1 (en) | 1989-08-02 | 
| PT89561A (pt) | 1989-10-04 | 
| ATE78161T1 (de) | 1992-08-15 | 
| DK37589D0 (da) | 1989-01-27 | 
| JPH01226817A (ja) | 1989-09-11 | 
| DE68902056D1 (de) | 1992-08-20 | 
| EP0326103B1 (en) | 1992-07-15 | 
| IE62426B1 (en) | 1995-02-08 | 
| DK37589A (da) | 1989-07-30 | 
| AR241632A1 (es) | 1992-10-30 | 
| DE68902056T2 (de) | 1992-12-03 | 
| GR3005792T3 (en:Method) | 1993-06-07 | 
Similar Documents
| Publication | Publication Date | Title | 
|---|---|---|
| GB2222772B (en) | Pharmaceutical compositions | |
| GB2219940B (en) | Pharmaceutical compositions | |
| EP0403578A4 (en) | Stable pharmaceutical composition | |
| GB8825892D0 (en) | Pharmaceutical composition | |
| HU896876D0 (en) | Pharmaceutical compositions | |
| ZA893422B (en) | Pharmaceutical composition | |
| EP0443027A4 (en) | Drug composition | |
| ZA89552B (en) | Pharmaceutical composition for 4-aroylimidazol-2-ones | |
| GB2217202B (en) | Trimelamol-containing pharmaceutical compositions | |
| GB8830406D0 (en) | Pharmaceutical compositions | |
| GB8802926D0 (en) | Pharmaceutical composition | |
| GB8827718D0 (en) | Pharmaceutical composition | |
| GB8818098D0 (en) | Pharmaceutical composition | |
| GB8802927D0 (en) | Pharmaceutical composition | |
| GB8818118D0 (en) | Pharmaceutical composition | |
| GB8809849D0 (en) | Pharmaceutical composition | |
| GB8807384D0 (en) | Pharmaceutical composition | |
| GB8806495D0 (en) | Pharmaceutical composition | |
| ZA893984B (en) | Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination | |
| GB8814146D0 (en) | Pharmaceutical compositions | |
| GB8830169D0 (en) | Pharmaceutical compositions | |
| ZA897139B (en) | Pharmaceutical compositions | |
| GB8808117D0 (en) | Pharmaceutical compositions | |
| GB8808830D0 (en) | Pharmaceutical compositions | |
| GB8809225D0 (en) | Pharmaceutical compositions |